Dexamethasone in Hospitalized Patients with Covid-19

Cited by (1,035)

Items 701–800 of 1,035

1. Calming the Storm: Natural Immunosuppressants as Adjuvants to Target the Cytokine Storm in COVID-19
   Angela E. Peter, B. V. Sandeep, B. Ganga Rao, V. Lakshmi Kalpana · 2021 · Frontiers in Pharmacology
2. Secondary infection with rhino-orbital cerebral mucormycosis associated with COVID-19
   Liane O. Dallalzadeh, Daniel J. Ozzello, Catherine Y. Liu, Don O. Kikkawa, Bobby S. Korn · 2021 · Orbit
3. LSE–Lancet Commission on the future of the NHS: re-laying the foundations for an equitable and efficient health and care service after COVID-19
   Michael Anderson, Emma Pitchforth, Miqdad Asaria, Carol Brayne, Barbara Casadei, Anita Charlesworth, Angela Coulter, Bryony Dean Franklin, Cam Donaldson, Michael Drummond et al. · 2021 · The Lancet
4. Efficacy of Inhaled Ciclesonide for Outpatient Treatment of Adolescents and Adults With Symptomatic COVID-19
   Brian M. Clemency, Renoj Varughese, Yaneicy Gonzalez‐Rojas, Caryn Gee Morse, Wanda Phipatanakul, David J. Koster, Michael S. Blaiss · 2021 · JAMA Internal Medicine
5. Efficacy Evaluation of Early, Low-Dose, Short-Term Corticosteroids in Adults Hospitalized with Non-Severe COVID-19 Pneumonia: A Retrospective Cohort Study
   Qiang Li, Weixia Li, Yinpeng Jin, Wei Xu, Chenlu Huang, Li Li, Yuxian Huang, Qingchun Fu, Liang Chen · 2020 · Infectious Diseases and Therapy
6. Nanotechnology for virus treatment
   Jiarong Zhou, Nishta Krishnan, Yao Jiang, Ronnie H. Fang, Liangfang Zhang · 2020 · Nano Today
7. Early versus deferred anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: A randomized phase II clinical trial
   María Elvira Balcells, Luis E. Rojas, Nicole Le Corre, Constanza Martínez-Valdebenito, María Elena Ceballos, Marcela Ferrés G, Mayling Chang, Cecilia Vizcaya, Sebastián Mondaca, Alvaro Huete G et al. · 2021 · PLoS Medicine
8. Chemokines and eicosanoids fuel the hyperinflammation within the lungs of patients with severe COVID-19
   Younes Zaid, Étienne Doré, Isabelle Dubuc, Anne‐Sophie Archambault, Olivier Flamand, Michel Laviolette, Nicolas Flamand, Éric Boilard, Louis Flamand · 2021 · Journal of Allergy and Clinical Immunology
9. Acute kidney injury in patients hospitalized with COVID-19 from the ISARIC WHO CCP-UK Study: a prospective, multicentre cohort study
   Michael K. Sullivan, Jennifer Susan Lees, Thomas M Drake, Annemarie Beth Docherty, Georgia Oates, Hayley E Hardwick, Clark D Russell, Laura Merson, Jake W Dunning, Jonathan S. Nguyen‐Van‐Tam et al. · 2021 · Nephrology Dialysis Transplantation
10. Oxidative stress-induced endothelial dysfunction and decreased vascular nitric oxide in COVID-19 patients
    Virginie Montiel, Irina I. Lobysheva, Ludovic Gérard, Marjorie Vermeersch, David L. Pérez-Morga, Thomas Castelein, Jean-Baptiste Mesland, Philippe E. Hantson, Christine Collienne, Damien Gruson et al. · 2022 · EBioMedicine
11. Outcome of COVID-19 in hospitalised immunocompromised patients: An analysis of the WHO ISARIC CCP-UK prospective cohort study
    Lance C. W. Turtle, Mathew Thorpe, Thomas M Drake, Maaike C. Swets, Carlo Palmieri, Clark D Russell, Antonia Ying Wai Ho, Stephen Aston, Dan Gower Wootton, Alex G Richter et al. · 2023 · PLoS Medicine
12. Computational drug repurposing: approaches, evaluation of in silico resources and case studies
    Ziaurrehman Tanoli, Adrià Fernández‐Torras, Umut Onur Özcan, Aleksandr Kushnir, Kristen Michelle Nader, Yojana Gadiya, Laura Fiorenza, Aleksandr Ianevski, Markus J. V. Vähä-Koskela, Mitro Miihkinen et al. · 2025 · Nature Reviews Drug Discovery
13. Risk of adverse coronavirus disease 2019 outcomes for people living with HIV
    Maya M. Mellor, Anne C. Bast, Nicholas Robert Jones, Nia Wyn Roberts, José Manuel Ordóñez-Mena, Alastair J.M. Reith, Christopher Butler, Philippa Clare Matthews, Jienchi Dorward · 2021 · AIDS
14. The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 – A systematic review of the literature
    Lucia Novelli, Francesca Motta, Maria De Santis, Aftab Ahmed Ansari, Merrill Eric Gershwin, Carlo Francesco Selmi · 2020 · Journal of Autoimmunity
15. Angiotensin-converting enzyme 2 (ACE2) expression increases with age in patients requiring mechanical ventilation
    Steven Andrew Baker, Shirley Kwok, Gerald J. Berry, Thomas Jude Montine · 2021 · PLoS ONE
16. Acute and Post-Acute Neurological Complications of COVID-19
    Ali Al-Ramadan, Omar Rabab’h, Jawad Shah, Abeer Gharaibeh · 2021 · Neurology International
17. Factors associated with mortality in patients with COVID‐19 admitted to intensive care: a systematic review and meta‐analysis
    Elliott H Taylor, Ella J Marson, Muhammed Elhadi, Kieran Macleod, Y. Yu, Ryan Alroy Davids, R. Boden, R. C. Overmeyer, Rema Ramakrishnan, David Alexander Thomson et al. · 2021 · Anaesthesia
18. Evaluation of Ivermectin as a Potential Treatment for Mild to Moderate COVID-19: A Double-Blind Randomized Placebo Controlled Trial in Eastern India
    Ravikirti, Ranjini Roy, Chandrima Pattadar, Rishav Raj, Neeraj Agarwal, Bijit Biswas, Pramod Kumar Manjhi, Deependra Kumar, Shyama Shyama, Anjani Kumar et al. · 2021 · Journal of Pharmacy & Pharmaceutical Sciences
19. A Visual and Comprehensive Review on COVID-19-Associated Pulmonary Aspergillosis (CAPA)
    Simon Feys, Maria Panagiota Almyroudi, Reinout Braspenning, Katrien Lagrou, Isabel Spriet, George Dimοpoulos, Joost Wauters · 2021 · Journal of Fungi
20. Efficacy of favipiravir in adults with mild COVID-19: a randomized, double-blind, multicentre, placebo-controlled clinical trial
    Mohammad Bosaeed, Ahmad M. Alharbi, Ebrahim Mahmoud, Sanaa Alrehily, Mohannad A. Bahlaq, Zied Gaifer, Hanan Alturkistani, Khaled Alhagan, Saad Alshahrani, Ali Tolbah et al. · 2022 · Clinical Microbiology and Infection
21. Clinical Characteristics and Outcomes of Patients With COVID-19–Associated Acute Respiratory Distress Syndrome Who Underwent Lung Transplant
    Chitaru Kurihara, Adwaiy Jayant Manerikar, Melissa Querrey, Christopher Felicelli, Anjana V. Yeldandi, Rafael Garza‐Castillon, Kalvin C. Lung, Samuel Kim, Bing Ho, Rade Tomic et al. · 2022 · JAMA
22. Sepsis and Coronavirus Disease 2019: Common Features and Anti-Inflammatory Therapeutic Approaches
    Jesús Beltrán-García, Rebeca Osca-Verdegal, Federico Vicente Pallardó, José Ferreres, María del Pilar Rodríguez, Sandra Mulet, Carolina Ferrando-Sánchez, Nieves Carbonell, Jose Luis García‐Giménez · 2020 · Critical Care Medicine
23. Randomized placebo-controlled pilot clinical trial on the efficacy of ayurvedic treatment regime on COVID-19 positive patients
    Ganpat Devpura, Balvir Singh Tomar, Deepak Nathiya, Abhishek Sharma, Deepak Bhandari, Swati Haldar, Acharya Balkrishna, Anurag Varshney · 2021 · Phytomedicine
24. The cytokine storms of COVID-19, H1N1 influenza, CRS and MAS compared. Can one sized treatment fit all?
    Gerwyn Morris, Chiara C. Bortolasci, Basant K. Puri, Wolfgang Marx, Adrienne E O'Neil, Eugene Athan, Ken R. Walder, Michael Berk, LISA S. OLIVE, Andre Ferrer Carvalho et al. · 2021 · Cytokine
25. Calcifediol Treatment and COVID-19–Related Outcomes
    Xavier Nogués, Diana Ovejero, Marta Pineda Moncusí, Roger Bouillon, Dolors Arenas, Julio Pascual, Anna Ribes, Robert Güerri‐Fernández, Judit Villar-García, Abora Rial‐Villavecchia et al. · 2021 · The Journal of Clinical Endocrinology & Metabolism
26. NF-κB Signaling and Inflammation—Drug Repurposing to Treat Inflammatory Disorders?
    Annabell Roberti, Laura Chaffey, David R. Greaves · 2022 · Biology
27. Reverse vaccinology assisted designing of multiepitope-based subunit vaccine against SARS-CoV-2
    Muhammad Tahir ul Qamar, Farah Shahid, S. Aslam, U. Ashfaq, Sidra Aslam, Israr Fatima, Muhammad Mazhar Fareed, A. Zohaib, Ling-Ling Chen · 2020 · Infectious Diseases of Poverty
28. Molecular Simulations suggest Vitamins, Retinoids and Steroids as Ligands of the Free Fatty Acid Pocket of the SARS‐CoV‐2 Spike Protein**
    Deborah K. Shoemark, Charlotte K. Colenso, Christine Toelzer, Kapil Gupta, Richard Barry Sessions, Andrew D. Davidson, Imre Berger, Christiane Schaffitzel, JAMES M. SPENCER, Adrian John Mulholland · 2021 · Angewandte Chemie International Edition
29. Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: An observational cohort study
    Giorgio Bozzi, Davide Mangioni, Francesca Minoia, Stefano Aliberti, Giacomo Grasselli, Laura Barbetta, Valeria Castelli, Emanuele Palomba, Laura Alagna, Andrea Lombardi et al. · 2020 · Journal of Allergy and Clinical Immunology
30. The cytokine storm and thyroid hormone changes in COVID-19
    Laura Croce, Dave Gangemi, G. Ancona, Federico Liboà, Giulia Bendotti, L. Minelli, L. Chiovato · 2021 · Journal of Endocrinological Investigation
31. Comparison of COVID-19 and influenza characteristics
    Yu Bai, Xiao‐Nan Tao · 2021 · Journal of Zhejiang University SCIENCE B
32. Tracheal aspirate RNA sequencing identifies distinct immunological features of COVID-19 ARDS
    Aartik A. Sarma, Stephanie A. Christenson, Ashley Byrne, Eran Mick, Angela Oliveira Pisco, Catherine DeVoe, Thomas J. Deiss, Rajani Ghale, Beth Shoshana Zha, Alexandra Tsitsiklis et al. · 2021 · Nature Communications
33. Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19
    Susanna Naggie, David R. Boulware, Christopher John Lindsell, Thomas G. Stewart, Nina Gentile, Sean P. Collins, Matthew William McCarthy, Dushyantha T. Jayaweera, Mario Castro, Mark Sulkowski et al. · 2022 · JAMA
34. COVID-19 bacteremic co-infection is a major risk factor for mortality, ICU admission, and mechanical ventilation
    Michael John Patton, Carlos Javier Orihuela, Kevin S. Harrod, Mohammad Alfrad Nobel Bhuiyan, Paari S. Dominic, Christopher G. Kevil, Daniel G. Fort, Vincent X. Liu, Maha Reda Farhat, Jonathan L. Koff et al. · 2023 · Critical Care
35. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome—An Observational Pilot Study
    Quirin Notz, Marc Schmalzing, Florian Wedekink, Tobias Schlesinger, Michael Gernert, Johannes Herrmann, Lena Sorger, Dirk Weismann, Benedikt Schmid, Magdalena Sitter et al. · 2020 · Frontiers in Immunology
36. Defective NET clearance contributes to sustained FXII activation in COVID-19-associated pulmonary thrombo-inflammation
    Hanna Englert, Chandini Rangaswamy, Carsten Deppermann, Jan‐Peter Sperhake, Christoph Krisp, Danny Schreier, Emma J. Gordon, Sandra Konrath, Munif Haddad, Giordano Pula et al. · 2021 · EBioMedicine
37. COVID-19 and the Endocrine System: A Comprehensive Review on the Theme
    Giuseppe Lisco, Anna De Tullio, Assunta Stragapede, Antonio Giovanni Solimando, Federica Albanese, Martina Capobianco, Vito Angelo Giagulli, Edoardo Guastamacchia, Giovanni De Pergola, Angelo Vacca et al. · 2021 · Journal of Clinical Medicine
38. Reduced humoral immune response after BNT162b2 coronavirus disease 2019 messenger RNA vaccination in cancer patients under antineoplastic treatment
    Marc Peeters, Lise Verbruggen, Laure-Anne Marie Nicole Teuwen, Greetje Vanhoutte, Sara Vande Kerckhove, Bart Peeters, Silke Raats, Isolde Van der Massen, Sven De Keersmaecker, Yana Debie et al. · 2021 · ESMO Open
39. Modelling metabolic diseases and drug response using stem cells and organoids
    Wenxiang Hu, Mitchell A. Lazar · 2022 · Nature Reviews Endocrinology
40. Role of SARS-CoV-2-induced cytokine storm in multi-organ failure: Molecular pathways and potential therapeutic options
    Yasaman Nazerian, Mobina Ghasemi, Younes Yassaghi, Amirhossein Nazerian, Seyed Mahmoud Hashemi · 2022 · International Immunopharmacology
41. Early corticosteroids are associated with lower mortality in critically ill patients with COVID-19: a cohort study
    Monedero, Pablo, Gea, Alfredo, Castro, Pedro, Candela-Toha, Angel M., Hernández-Sanz, María L., Arruti, Egoitz, Villar, Jesús, Ferrando, Carlos, the COVID-19 Spanish ICU Network, Monedero, Pablo et al. · 2021 · Critical Care
42. Compartmental immunophenotyping in COVID-19 ARDS: A case series
    Andreas Ronit, Ronan M. G. Berg, Jakob Thaning Bay, Anna Karen Haugaard, Magnus Glindvad Ahlström, Kristoffer Sølvsten Burgdorf, Henrik Ullum, Sara Bird Rørvig, Klaus Tjelle Kristiansen, Nicolai Bang Foss et al. · 2020 · Journal of Allergy and Clinical Immunology
43. COVID-19 outcomes in patients waitlisted for kidney transplantation and kidney transplant recipients
    Rebecca Craig‐Schapiro, Thalia Salinas, Michelle Lubetzky, Brittany T. Abel, Samuel T. Sultan, John R. Lee, Sandip Kapur, Meredith J. Aull, Darshana M. Dadhania · 2020 · American Journal of Transplantation
44. COVID-19: Understanding Inter-Individual Variability and Implications for Precision Medicine
    Naveen L. Pereira, Ferhaan Ahmad, Mirnela Byku, Nathan W. Cummins, Alanna A. Morris, ANJALI TIKU OWENS, Sony Tuteja, Sharon Cresci · 2020 · Mayo Clinic Proceedings
45. The end of the COVID‐19 pandemic
    John P. A. Ioannidis · 2022 · European Journal of Clinical Investigation
46. COVID-19: neonatal–perinatal perspectives
    On behalf of the Harvard Neonatal-Perinatal Fellowship COVID-19 Working Group, Barrero-Castillero, Alejandra, Beam, Kristyn S., Bernardini, Laura B., Ramos, Erika G. Cordova, Davenport, Patricia E., Duncan, Anna R., Fraiman, Yarden S., Frazer, Lauren C., Healy, Helen et al. · 2021 · Journal of Perinatology
47. COVID‐19 drug repurposing: A review of computational screening methods, clinical trials, and protein interaction assays
    Xueqing Wang, Yuanfang Guan · 2020 · Medicinal Research Reviews
48. Inflammatory phenotyping predicts clinical outcome in COVID-19
    Hannah Burke, Anna T. Freeman, Doriana Cellura, Beth L. Stuart, Nathan James Brendish, Stephen Poole, Florina Borca, Hang T. T. Phan, Natasha Sheard, Sarah V. Williams et al. · 2020 · Respiratory Research
49. Factors of Severity in Patients with COVID-19: Cytokine/Chemokine Concentrations, Viral Load, and Antibody Responses
    Ji‐Soo Kwon, Ji Yeun Kim, Min‐Chul Kim, Se Yoon Park, Baek-Nam Kim, Seongman Bae, Hye Hee Cha, Jiwon Jung, Minjae Kim, Myung Jin Lee et al. · 2020 · American Journal of Tropical Medicine and Hygiene
50. How to manage patients with corticosteroids in oncology in the era of immunotherapy?
    Mihaela D. Aldea, Émeline Orillard, Laura Mansi, Aurélien Marabelle, Florian Scotté, Olivier Lambotte, Jean‐Marie Michot · 2020 · European Journal of Cancer
51. Severe organising pneumonia following COVID-19
    István Vadász, Faeq Husain‐Syed, Peter Dorfmüller, Fritz Christian Roller, Khodr Tello, Matthias Hecker, Rory Edward Morty, Stefan Gattenlöhner, Hans‐Dieter Walmrath, Friedrich Grimminger et al. · 2020 · Thorax
52. A multi-pronged approach targeting SARS-CoV-2 proteins using ultra-large virtual screening
    Christoph Gorgulla, Krishna Mohan Das, Kendra E. Leigh, Marco Cespugli, Patrick D. Fischer, Zifu Wang, Guilhem Tesseyre, Shreya Pandita, Alec Shnapir, Anthony Calderaio et al. · 2021 · iScience
53. Nanomedicine for the SARS-CoV-2: State-of-the-Art and Future Prospects
    Sree Pooja Varahachalam, Behnaz Lahooti, Masoumeh Chamaneh, Sounak Bagchi, Tanya Chhibber, Kevin Morris, Joe F. Bolanos, Nam‐Young Kim, Ajeet Kumar Kaushik · 2021 · International Journal of Nanomedicine
54. Current and Emerging Knowledge in COVID-19
    Yeon Joo Jeong, Yu Mi Wi, Hyunjin Park, Jong Eun Lee, Si‐Ho Kim, Kyung Soo Lee · 2023 · Radiology
55. Inflammation and aging-related disease: A transdisciplinary inflammaging framework
    Brian J. Andonian, Joseph A. Hippensteel, Katrina Abuabara, Eileen Mary Boyle, James F. Colbert, Michael J. Devinney, Adam S. Faye, Bharati D. Kochar, Jiha Lee, Rachel R Litke et al. · 2024 · GeroScience
56. Impact of Early Pandemic Stage Mutations on Molecular Dynamics of SARS-CoV‑2 Mpro
    Olivier Sheik Amamuddy, Gennady M. Verkhivker, Özlem Taştan Bishop · 2020 · Journal of Chemical Information and Modeling
57. Cytokine Storms in Cancer and COVID-19
    Casmir Turnquist, B. Ryan, I. Horikawa, B. T. Harris, C. Harris · 2020 · Cancer Cell
58. Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: A retrospective observational study (COQUIMA cohort)
    Pablo Guisado‐Vasco, Sofia Valderas-Ortega, María Maravillas Carralón-González, Ana Roda Santacruz, Lucía González‐Cortijo, Gabriel Sotres-Fernández, Eva María Martí-Ballesteros, José Manuel Luque-Pinilla, Elena Almagro, Félix Lacoma Lanuza et al. · 2020 · EClinicalMedicine
59. The Circadian Clock and Viral Infections
    Helene Borrmann, Jane A. McKeating, Xiaodong Alan Zhuang · 2020 · Journal of Biological Rhythms
60. CXCL10 could drive longer duration of mechanical ventilation during COVID-19 ARDS
    Mathieu Blot, Marine Jacquier, Serge Aho, Guillaume Beltramo, Maxime Nguyen, Philippe Bonniaud, Sébastien Prin, Pascal Andreu, Bélaïd Bouhemad, Jean‐Baptiste Bour et al. · 2020 · Critical Care
61. KG-COVID-19: A Framework to Produce Customized Knowledge Graphs for COVID-19 Response
    Justin Reese, Deepak Raveendran Unni, Tiffany J. Callahan, Luca Cappelletti, Vida Ravanmehr, Seth Carbon, Kent Shefchek, Benjamin M. Good, James P. Balhoff, Tommaso Fontana et al. · 2020 · Patterns
62. Acute covid-19 and multisystem inflammatory syndrome in children
    Jessica H. Rubens, Nadine Peart Akindele, Megan M. Tschudy, Anna C. Sick-Samuels · 2021 · BMJ
63. COVID-19 and thrombotic microangiopathies
    Nishant R. Tiwari, Sanat B. Phatak, Vivek R. Sharma, Sanjay Kumar Agarwal · 2021 · Thrombosis Research
64. Diabetes, COVID 19 and mucormycosis: Clinical spectrum and outcome in a tertiary care medical center in Western India
    Yogendra Mishra, Manoj Prashar, Deepak Kumar Sharma, Akash Akash, V.Pravin Kumar, TVSVGK Tilak · 2021 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
65. Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trial
    Timothy Hinks, Lucy Cureton, Ruth Knight, Ariel Wang, Jennifer Cane, Vicki S Barber, Joanna Black, Susan Dutton, James Melhorn, Maisha Jabeen et al. · 2021 · The Lancet Respiratory Medicine
66. Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance
    Manuel Francisco Ugarte-Gil, Graciela S. Alarcón, Zara Izadi, Alí Duarte‐García, Cristina Reátegui-Sokolova, Ann Elaine Clarke, Leanna Marderian Wise, Guillermo Pons‐Estel, María José Santos, Sasha Bernatsky et al. · 2022 · Annals of the Rheumatic Diseases
67. Nanomaterials for Photocatalytic Degradations of Analgesic, Mucolytic and Anti-Biotic/Viral/Inflammatory Drugs Widely Used in Controlling SARS-CoV-2
    Mahsa Ebrahimi, Omid Akhavan · 2022 · Catalysts
68. Effect of Corticosteroids on Mortality and Clinical Cure in Community-Acquired Pneumonia
    Naveed Saleem, Adarsh Kulkarni, Timothy Arthur Chandos Snow, Gareth Ambler, Mervyn Singer, Nishkantha Arulkumaran · 2022 · CHEST Journal
69. Multi-omics-based identification of SARS-CoV-2 infection biology and candidate drugs against COVID-19
    Barh, Debmalya, Tiwari, Sandeep, Weener, Marianna E., Azevedo, Vasco, Góes-Neto, Aristóteles, Gromiha, M. Michael, Ghosh, Preetam · 2020 · Computers in Biology and Medicine
70. COVID-19 in patients with systemic lupus erythematosus: lessons learned from the inflammatory disease
    Ruth Fernandez‐Ruiz, Jacqueline L Paredes, Timothy B. Niewold · 2020 · Translational research
71. Characteristics of viral pneumonia in the COVID-19 era: an update
    Pasquale Pagliano, Carmine Sellitto, Valeria Conti, Tiziana Ascione, Silvano Esposito · 2021 · Infection
72. Invasive mould disease in fatal COVID-19: a systematic review of autopsies
    Brittany Kula, Cornelius Joseph Clancy, M. Hong Nguyen, Ilan Steven Schwartz · 2021 · The Lancet Microbe
73. Association of vitamin D status with COVID-19 and its severity
    Jae Hyun Bae, Hun Jee Choe, Michael F. Holick, Soo Kyung Lim · 2022 · Reviews in Endocrine and Metabolic Disorders
74. A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19
    Yogiraj Ray, Shekhar Ranjan Paul, Purbita Bandopadhyay, Ranit D’Rozario, Jafar Sarif, Deblina Raychaudhuri, Debaleena Bhowmik, Abhishake Lahiri, Janani Srinivasa Vasudevan, Ranjeet Maurya et al. · 2022 · Nature Communications
75. IgM anti-ACE2 autoantibodies in severe COVID-19 activate complement and perturb vascular endothelial function
    Livia A Casciola-Rosen, David R. Thiemann, Felipe Andrade, Maria Isabel Trejo‐Zambrano, Elissa K. Leonard, Jamie B. Spangler, Nicole Skinner, Justin R. Bailey, Srinivasan Yegnasubramanian, Rulin Wang et al. · 2022 · JCI Insight
76. Long-Term Cardiovascular Effects of COVID-19: Emerging Data Relevant to the Cardiovascular Clinician
    Diana L. Tobler, Alix J. Pruzansky, Sahar Naderi, Andrew P. Ambrosy, Justin J. Slade · 2022 · Current Atherosclerosis Reports
77. Retracted: Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection
    Andrew Martin Hill, Ahmed Abdulamir, Sabeena Ahmed, Asma Asghar, Olufemi Emmanuel Babalola, Rabia Basri, Carlos Chaccour, Aijaz Zeeshan Khan Chachar, Abu Tauib Mohammed Chowdhury, Ahmed Elgazzar et al. · 2021 · Open Forum Infectious Diseases · Retracted
78. Anakinra for patients with COVID-19: a meta-analysis of non-randomized cohort studies.
    Laura Pasin, Giulio Cavalli, Paolo Navalesi, Nicolò Sella, Giovanni Landoni, Andrey G. Yavorovskiy, Valery V. Likhvantsev, Alberto Zangrillo, Lorenzo Dagna, Giacomo Monti · 2021 · European Journal of Internal Medicine
79. The Surviving Sepsis Campaign: Research Priorities for Coronavirus Disease 2019 in Critical Illness
    Craig M. Coopersmith, Massimo M. Antonelli, Seth R. Bauer, Clifford Scott Deutschman, Laura Evans, Ricard Ferrer, Judith Hellman, Sameer Jog, Jozef Kesecioğlu, Niranjan “Tex” Kissoon et al. · 2021 · Critical Care Medicine
80. Is severe COVID-19 a cytokine storm syndrome: a hyperinflammatory debate
    Puja Mehta, David C. Fajgenbaum · 2021 · Current Opinion in Rheumatology
81. A high-resolution temporal atlas of the SARS-CoV-2 translatome and transcriptome
    Doyeon Kim, Sukjun Kim, Joori Park, Hee Ryung Chang, Jeeyoon Chang, Junhak Ahn, Heedo Park, June‐Hee Park, Narae Son, Gihyeon Kang et al. · 2021 · Nature Communications
82. Potent Anti-SARS-CoV-2 Activity by the Natural Product Gallinamide A and Analogues via Inhibition of Cathepsin L
    Anneliese S. Ashhurst, Arthur H. Tang, Pavla Fajtová, Michael C. Yoon, Anupriya Aggarwal, Max J. Bedding, Alexander Stoye, Laura Beretta, Dustin Pwee, Aleksandra K. Drelich et al. · 2021 · Journal of Medicinal Chemistry
83. The COVID-19 Drug and Gene Set Library
    Maxim V. Kuleshov, Daniel J. Stein, Daniel J. B. Clarke, Eryk Kropiwnicki, Kathleen M. Jagodnik, Alon Bartal, John Erol Evangelista, Jason Hom, Minxuan Cheng, Allison Bailey et al. · 2020 · Patterns
84. Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies
    Omar Hasan Ali, David Bomze, Lorenz Risch, Silvio D. Brugger, Matthias Paprotny, Myriam C. Weber, Sarah L. Thiel, Lukas Kern, Werner C. Albrich, Philipp P. Kohler et al. · 2020 · Clinical Infectious Diseases
85. Remdesivir Strongly Binds to Both RNA-Dependent RNA Polymerase and Main Protease of SARS-CoV-2: Evidence from Molecular Simulations
    Hoang Linh Nguyen, Nguyen Quoc Thai, Duc Toan Truong, Mai Suan Li · 2020 · The Journal of Physical Chemistry B
86. Outcomes for patients with COVID‐19 admitted to Australian intensive care units during the first four months of the pandemic
    Aidan J. C. Burrell, Breanna Pellegrini, Farhad Salimi, Husna Begum, Tessa Broadley, Lewis T. Campbell, Allen C Cheng, Winston Cheung, David James Cooper, Arul Earnest et al. · 2020 · The Medical Journal of Australia
87. Ozone-Induced Oxidative Stress, Neutrophilic Airway Inflammation, and Glucocorticoid Resistance in Asthma
    Chioma Enweasor, Cameron H. Flayer, Angela Haczku · 2021 · Frontiers in Immunology
88. COVID-19: Inflammatory Profile
    Yuhang Wang, Stanley M. Perlman · 2021 · Annual Review of Medicine
89. Emerging Fungal Infections: New Species, New Names, and Antifungal Resistance
    Nathan P. Wiederhold · 2021 · Clinical Chemistry
90. Aging, inflammaging and immunosenescence as risk factors of severe COVID-19
    Anteneh Mehari Tizazu, Hylemariam Mihiretie Mengist, Gebreselassie Demeke · 2022 · Immunity & Ageing
91. Coronavirus disease 2019 outcomes among patients with rheumatic diseases 6 months into the pandemic
    Naomi J. Serling-Boyd, Kristin M. D’Silva, Tiffany Y. T. Hsu, Rachel S. Wallwork, Xiaoqing Fu, Ellen M. Gravallese, April M Jorge, Yuqing Zhang, Hyon K. Choi, Jeffrey A. Sparks et al. · 2020 · Annals of the Rheumatic Diseases
92. The role of organizational characteristics on the outcome of COVID-19 patients admitted to the ICU in Belgium
    Fabio Silvio Taccone, Nina Van Goethem, Robby De Pauw, Xavier Wittebole, Koen Y. Blot, Herman J. Van Oyen, Tinne Lernout, Marion Montourcy, Geert Meyfroidt, Dominique Van Beckhoven · 2020 · The Lancet Regional Health - Europe
93. Similarities and Dissimilarities of COVID-19 and Other Coronavirus Diseases
    To Sing Fung, Ding Xiang Liu · 2021 · Annual Review of Microbiology
94. JAK inhibitors: Ten years after
    Francesca Romana Spinelli, Françoise Meylan, John J. O’Shea, Massimo Gadina · 2021 · European Journal of Immunology
95. Antibiotics for the treatment of COVID-19
    Maria Popp, Miriam Songa Stegemann, Manuel Riemer, Maria‐Inti Metzendorf, Carolina Soledad Romero, Agata Mikołajewska, Peter Kranke, Patrick Meybohm, Nicole Skoetz, Stephanie Weibel · 2021 · Cochrane Database of Systematic Reviews
96. Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy
    Elise M. N. Ferré, Monica M. Schmitt, Michail S. Lionakis · 2021 · Frontiers in Pediatrics
97. Predictors and microbiology of respiratory and bloodstream bacterial infection in patients with COVID-19: living rapid review update and meta-regression
    Bradley J. Langford, Miranda So, Valerie Leung, Sumit Raybardhan, Jennifer Lo, Tiffany Kan, Felicia Leung, Duncan J. Westwood, Nick Daneman, Derek R. MacFadden et al. · 2021 · Clinical Microbiology and Infection
98. Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients
    Mila Brum Ortigoza, Hyunah Yoon, Keith S. Goldfeld, Andrea B. Troxel, Johanna Patricia Daily, Yinxiang Wu, Yi Li, Danni Wu, Gia Cobb, Gillian G. Baptiste et al. · 2021 · JAMA Internal Medicine
99. SARS-CoV-2 Infects Red Blood Cell Progenitors and Dysregulates Hemoglobin and Iron Metabolism
    Romy Kronstein‐Wiedemann, Marlena Stadtmüller, Sofia Traikov, Mandy Georgi, Madeleine Teichert, Hesham K. Yosef, Jan Wallenborn, Andreas Karl, Karin Schütze, Michael Wagner et al. · 2022 · Stem Cell Reviews and Reports
100. Niclosamide—A promising treatment for COVID‐19
     Shivani Singh, Anne Weiss, James A Goodman, Marie Fisk, Spoorthy Kulkarni, Ing Ni Lu, Joanna Gray, Rona Smith, Morten Otto Alexander Sommer, Joseph Cheriyan · 2022 · British Journal of Pharmacology